Reimbursement decisions significantly impact market access in Japan by determining a medical device’s affordability and adoption under the NHI system. Positive decisions enable widespread use in the healthcare system, while unfavorable outcomes may limit market entry. Pricing, classification, and alignment with NHI criteria influence a device’s competitiveness and accessibility in Japan.
